Mannan-binding lectin serum concentrations in HIV-infected patients are influenced by the stage of disease

Immunol Lett. 1997 Aug;58(3):171-5. doi: 10.1016/s0165-2478(97)00084-9.

Abstract

Serum concentrations of mannan-binding lectin (MBL) were determined in the sera of 67 HIV-seropositive patients in different stages of HIV disease and in the sera of 75 HIV-seronegative healthy individuals. In the asymptomatic (AS) HIV-infected persons MBL concentrations were found to be significantly (P < 0.05) lower than in the HIV-seronegative controls, whereas in the AIDS patients they were not. Very low (< or = 25 ng/ml) MBL serum concentrations were detected in 5/19 (26.3%) and 7/75 (9.3%) of the AS HIV-seropositive and HIV-seronegative individuals, respectively (P = 0.06). In the sera of the HIV-infected patients, MBL levels positively correlated to the neopterin concentrations (Spearman correlation coefficient, 0.401, P = 0.0009) while they negatively correlated to the percentage (-0.447, P = 0.0011) and absolute number (-0.453, P = 0.0012) of the CD4+ lymphocytes. These observations indicate that MBL level, which is under strict genetic control, may influence the susceptibility to HIV infection and the progression of HIV disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Proteins / metabolism*
  • CD4-Positive T-Lymphocytes
  • Carrier Proteins / blood*
  • Collectins
  • Disease Progression
  • HIV Infections / blood*
  • HIV Infections / immunology
  • Humans
  • Lectins / blood*
  • Mannans / blood*
  • Neopterin / blood
  • T-Lymphocyte Subsets

Substances

  • Blood Proteins
  • Carrier Proteins
  • Collectins
  • Lectins
  • Mannans
  • Neopterin